CRP regulates the expression and activity of tissue factor as well as tissue factor pathway inhibitor via NF-κB and ERK 1/2 MAPK pathway

FEBS Letters

Volumn 583, Issue 17, 2009, Pages 2811-2818

  Chen, YangXin ^a   Wang, JingFeng ^a   Yao, YouJie ^a   Yuan, WoLiang ^a   Kong, MinYi ^a   Lin, YongQing ^a   Geng, DengFeng ^a   Nie, RuQiong ^a  

^a SUN YAT SEN UNIVERSITY   (China)

Author keywords

C reactive protein; Human umbilical vein endothelial cell; Tissue factor; Tissue factor pathway inhibitor

Indexed keywords

1,4 DIAMINO 1,4 BIS(2 AMINOPHENYLTHIO) 2,3 DICYANOBUTADIENE; C REACTIVE PROTEIN; FC RECEPTOR; I KAPPA B BETA; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PYRROLIDINE DITHIOCARBAMATE; THROMBOPLASTIN; TISSUE FACTOR PATHWAY INHIBITOR; TRANSCRIPTION FACTOR RELA;

ARTICLE; BLOOD CLOTTING; CONCENTRATION RESPONSE; CONTROLLED STUDY; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN DNA BINDING; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; UMBILICAL VEIN; VASCULAR ENDOTHELIUM;

ANTIBODIES; C-REACTIVE PROTEIN; CELLS, CULTURED; ENDOTHELIAL CELLS; ENZYME INHIBITORS; HUMANS; LIPOPROTEINS; MAP KINASE SIGNALING SYSTEM; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; NF-KAPPA B; RECEPTORS, IGG; THROMBOPLASTIN;

EID: 69249205355     PISSN: 00145793     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.febslet.2009.07.037     Document Type: Article

References (32)

1. Ross R. Atherosclerosis - an inflammatory disease. N. Engl. J. Med. 340 (1999) 115-126
2. Libby P. Inflammation in atherosclerosis. Nature 420 (2002) 868-874
3. Yan Z.Q., and Hansson G.K. Innate immunity, macrophage activation, and atherosclerosis. Immunol. Rev. 219 (2007) 187-203
4. Sattar N., Murray H.M., McConnachie A., Blauw G.J., Bollen E.L., Buckley B.M., PROSPER Study Group, et al. C-reactive protein and prediction of coronary heart disease and global vascular events in the Prospective Study of Pravastatin in the Elderly at Risk (PROSPER). Circulation 115 (2007) 981-989
5. Kavsak P.A., MacRae A.R., Newman A.M., Lustig V., Palomaki G.E., Ko D.T., et al. Elevated C-reactive protein in acute coronary syndrome presentation is an independent predictor of long-term mortality and heart failure. Clin. Biochem. 40 (2007) 326-329
6. Shimada K., Fujita M., Tanaka A., Yoshida K., Jisso S., Tanaka H., JCAD Investigators, et al. Elevated serum C-reactive protein levels predict cardiovascular events in the Japanese coronary artery disease (JCAD) study. Circ. J. 73 (2009) 78-85
7. Bisoendial R.J., Kastelein J.J., Levels J.H., Zwaginga J.J., van den Bogaard B., Reitsma P.H., et al. Activation of inflammation and coagulation after infusion of C-reactive protein in humans. Circ. Res. 96 (2005) 714-716
8. Bisoendial R.J., Kastelein J.J., Peters S.L., Levels J.H., Birjmohun R., Rotmans J.I., et al. Effects of CRP infusion on endothelial function and coagulation in normocholesterolemic and hypercholesterolemic subjects. J. Lipid Res. 48 (2007) 952-960
9. Verma S., Devaraj S., and Jialal I. Is CRP an innocent bystander or proatherogenic culprit? CRP promotes atherothrombosis. Circulation 113 (2006) 2135-2150
10. Wilson A.M., Ryan M.C., and Boyle A.J. The novel role of C-reactive protein in cardiovascular disease: risk marker or pathogen. Int. J. Cardiol. 106 (2006) 291-297
11. Paffen E., and DeMaat M.P. C-reactive protein in atherosclerosis: a causal factor?. Cardiovasc. Res. 71 (2006) 30-39
12. Hatakeyama K., Asada Y., Marutsuka K., Sato Y., Kamikubo Y., and Sumiyoshi A. Localization and activity of tissue factor in human aortic atherosclerotic lesions. Atherosclerosis 133 (1997) 213-219
13. Ardissino D., Merlini P.A., Ariëns R., Coppola R., Bramucci E., and Mannucci P.M. Tissue-factor antigen and activity in human coronary atherosclerotic plaques. Lancet 349 (1997) 769-771
14. Kaikita K., Takeya M., Ogawa H., Suefuji H., Yasue H., and Takahashi K. Co-localization of tissue factor and tissue factor pathway inhibitor in coronary atherosclerosis. J. Pathol. 188 (1999) 180-188
15. Steffel J., Akhmedov A., Greutert H., Lüscher T.F., and Tanner F.C. Histamine induces tissue factor expression: implications for acute coronary syndromes. Circulation 112 (2005) 341-349
16. Steffel J., Lüscher T.F., and Tanner F.C. Tissue factor in cardiovascular diseases: molecular mechanisms and clinical implications. Circulation 113 (2006) 722-731
17. Sternik L., Samee S., Schaff H.V., Zehr K.J., Lerman L.O., Holmes D.R., et al. C-reactive protein relaxes human vessels in vitro. Arterioscler. Thromb. Vasc. Biol. 22 (2002) 1865-1868
18. Clapp B.R., Hirschfield G.M., Storry C., Gallimore J.R., Stidwill R.P., Singer M., et al. Inflammation and endothelial function: direct vascular effects of human C-reactive protein on nitric oxide bioavailability. Circulation 111 (2005) 1530-1536
19. Kuo L., Chilian W.M., Davis M.J., and Laughlin M.H. Endotoxin impairs flow-induced vasodilation of porcine coronary arterioles. Am. J. Physiol. 262 (1992) H1838-H1845
20. Bisoendial R.J., Kastelein J.J., and Stroes E.S. C-reactive protein and atherogenesis: from fatty streak to clinical event. Atherosclerosis 195 (2007) e10-e18
21. Shah P.K. Inflammation and plaque vulnerability. Cardiovasc. Drugs Ther. 23 (2009) 31-40
22. Jacobs M., van Greevenbroek M.M., van der Kallen C.J., Ferreira I., Blaak E.E., Feskens E.J., et al. Low-grade inflammation can partly explain the association between the metabolic syndrome and either coronary artery disease or severity of peripheral arterial disease: the CODAM study. Eur. J. Clin. Invest. 39 (2009) 437-444
23. Brambilla M., Camera M., Colnago D., Marenzi G., De Metrio M., Giesen P.L., et al. Tissue factor in patients with acute coronary syndromes: expression in platelets, leukocytes, and platelet-leukocyte aggregates. Arterioscler. Thromb. Vasc. Biol. 28 (2008) 947-953
24. Lima L.M., Sousa M.O., Dusse L.M., Lasmar M.C., das Graças Carvalho M., and Lwaleed B.A. Tissue factor and tissue factor pathway inhibitor levels in coronary artery disease: correlation with the severity of atheromatosis. Thromb. Res. 121 (2007) 283-287
25. Xu P., Qi X.Y., Li C.H., Zhang J.H., Liu D.M., Liu J., et al. Plasma tissue factor and tissue factor pathway inhibitor levels in acute myocardial infarction patients with no-reflow during percutaneous coronary intervention. Zhonghua Xin Xue Guan Bing Za Zhi 36 (2008) 1013-1015 (in Chinese)
26. Taylor K.E., Giddings J.C., and van den Berg C.W. C-reactive protein-induced in vitro endothelial cell activation is an artefact caused by azide and lipopolysaccharide. Arterioscler. Thromb. Vasc. Biol. 25 (2005) 1225-1230
27. Liu C., Wang S., Deb A., Nath K.A., Katusic Z.S., McConnell J.P., et al. Proapoptotic, antimigratory, antiproliferative, and antiangiogenic effects of commercial C-reactive protein on various human endothelial cell types in vitro: implications of contaminating presence of sodium azide in commercial preparation. Circ. Res. 97 (2005) 135-143
28. Pepys M.B., Hawkins P.N., Kahan M.C., Tennent G.A., Gallimore J.R., Graham D., et al. Proinflammatory effects of bacterial recombinant human C-reactive protein are caused by contamination with bacterial products, not by C-reactive protein itself. Circ. Res. 97 (2005) 97-103
29. Kuhlmann C.R., Librizzi L., Closhen D., Pflanzner T., Lessmann V., Pietrzik C.U., et al. Mechanisms of C-reactive protein-induced blood-brain barrier disruption. Stroke 40 (2009) 1458-1466
30. Montero I., Orbe J., Varo N., Beloqui O., Monreal J.I., Rodríguez J.A., et al. C-reactive protein induces matrix metalloproteinase-1 and -10 in human endothelial cells: implications for clinical and subclinical atherosclerosis. J. Am. Coll. Cardiol. 47 (2006) 1369-1378
31. Wang Q., Zhu X., Xu Q., Ding X., Chen Y.E., and Song Q. Effect of C-reactive protein on gene expression in vascular endothelial cells. Am. J. Physiol. Heart Circ. Physiol. 288 (2005) H1539-H1545
32. Wu J., Stevenson M.J., Brown J.M., Grunz E.A., Strawn T.L., and Fay W.P. C-reactive protein enhances tissue factor expression by vascular smooth muscle cells: mechanisms and in vivo significance. Arterioscler. Thromb. Vasc. Biol. 28 (2008) 698-704